We are live on
!
Find out more
BCI
Brinker Capital Investments Portfolio holdings
AUM
$11.7B
1-Year Est. Return
21.33%
This Fund
S&P 500
This Quarter
Est. Return
-12.84%
1 Year Est. Return
+21.33%
3 Year Est. Return
+58.92%
5 Year Est. Return
+67.24%
10 Year Est. Return
+168.88%
AUM
$5.28B
AUM Growth
-$1.22B
(-19%)
Cap. Flow
-$341M
Cap. Flow
% of AUM
-6.45%
Top 10 Holdings %
Top 10 Hldgs %
16.97%
Holding
1,449
New
74
Increased
548
Reduced
694
Closed
100
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
BNY Mellon Concentrated International ETF
BKCI
|
+$32.8M |
| 2 |
Franklin Systematic Style Premia ETF
FLSP
|
+$22.9M |
| 3 |
Vanguard Morningstar Growth ETF
VUG
|
+$12M |
| 4 |
Vanguard Short-Term Corporate Bond ETF
VCSH
|
+$10.4M |
| 5 |
IQVIA
IQV
|
+$9.87M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 1000 Growth ETF
IWF
|
+$48.4M |
| 2 |
First Trust Europe AlphaDEX Fund
FEP
|
+$37M |
| 3 |
Vanguard Morningstar Total Stock Market ETF
VTI
|
+$33.8M |
| 4 |
iShares Core MSCI EAFE ETF
IEFA
|
+$27M |
| 5 |
IQ ARB Merger Arbitrage ETF
MNA
|
+$26.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.14% |
| 2 | Healthcare | 10.35% |
| 3 | Financials | 8.84% |
| 4 | Industrials | 6.48% |
| 5 | Consumer Discretionary | 5.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
Neurocrine Biosciences
NBIX
$16.6B
| $3.27M | 0.06% |
33,573
+99
| +0.3% | +$9.14K |
|
302
Churchill Downs
CHDN
$6.12B
| $3.26M | 0.06% |
34,034
+5,130
| +18% | +$510K |
|
303
Keysight
KEYS
$58.3B
| $3.25M | 0.06% |
23,591
-717
| -3% | -$102K |
|
304
Power Integrations
POWI
$3.61B
| $3.23M | 0.06% |
43,060
-55
| -0.1% | -$4.46K |
|
|
FTF
305
Franklin Limited Duration Income Trust
FTF
$233M
| $3.21M | 0.06% |
474,045
+17,976
| +4% | +$126K |
|
306
Cardinal Health
CAH
$55.4B
| $3.2M | 0.06% |
61,173
-2,262
| -4% | -$129K |
|
307
Aflac
AFL
$62.6B
| $3.19M | 0.06% |
57,706
-2,254
| -4% | -$133K |
|
|
JHMH
308
DELISTED
John Hancock Multifactor Healthcare ETF
JHMH
| $3.19M | 0.06% |
70,131
-2,732
| -4% | -$128K |
|
309
FTI Consulting
FCN
$4.18B
| $3.18M | 0.06% |
17,606
-1,847
| -9% | -$305K |
|
310
Principal Spectrum Preferred Securities Active ETF
PREF
$1.78B
| $3.13M | 0.06% |
181,421
+20,203
| +13% | +$364K |
|
311
Travelers Companies
TRV
$80.2B
| $3.12M | 0.06% |
18,440
-1,065
| -5% | -$185K |
|
|
EMTL
312
DELISTED
State Street DoubleLine Emerging Markets Fixed Income ETF
EMTL
| $3.11M | 0.06% |
+75,271
| New | +$3.23M |
|
313
KLA
KLAC
$259B
| $3.1M | 0.06% |
97,140
+10,790
| +12% | +$363K |
|
|
ABB
314
DELISTED
ABB Ltd
ABB
| $3.08M | 0.06% |
115,196
-5,092
| -4% | -$151K |
|
315
AptarGroup
ATR
$8.61B
| $3.06M | 0.06% |
29,644
-5,517
| -16% | -$602K |
|
316
Trane Technologies
TT
$106B
| $3.02M | 0.06% |
23,215
-1,357
| -6% | -$188K |
|
317
Alibaba
BABA
$308B
| $3.01M | 0.06% |
26,500
+11,734
| +79% | +$1.15M |
|
318
EPAM Systems
EPAM
$5.03B
| $3.01M | 0.06% |
10,216
+1,084
| +12% | +$331K |
|
319
Cognizant
CTSH
$26B
| $2.99M | 0.06% |
44,263
-39,318
| -47% | -$3.01M |
|
320
Alexandria Real Estate Equities
ARE
$8.56B
| $2.98M | 0.06% |
20,525
-335
| -2% | -$56.8K |
|
321
Take-Two Interactive
TTWO
$46.1B
| $2.97M | 0.06% |
24,260
+3,010
| +14% | +$383K |
|
322
Genuine Parts
GPC
$18.7B
| $2.97M | 0.06% |
22,322
-1,736
| -7% | -$231K |
|
323
Goldman Sachs ActiveBeta International Equity ETF
GSIE
$6.16B
| $2.96M | 0.06% |
106,760
-63,688
| -37% | -$1.93M |
|
324
Bio-Rad Laboratories Class A
BIO
$9.42B
| $2.96M | 0.06% |
5,985
-184
| -3% | -$95.8K |
|
325
Edison International
EIX
$26.4B
| $2.96M | 0.06% |
46,744
-12,114
| -21% | -$821K |
|
Similar funds
VA
HTC
NYLIM
PI
UE
LC
MIFH
DWM
Brinker Capital Investments's Q2 2022 Portfolio in Review
As of Q2 2022, Brinker Capital Investments held 1,449 positions worth $5.28B, down 19% from $6.5B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Brinker Capital Investments withdrew a net $341M in Q2 2022, closing 100 positions and reducing 694 holdings. Its most notable exit was First Trust Europe AlphaDEX Fund, an estimated $37M position sold in full.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 13% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Brinker Capital Investments opened a new position in BNY Mellon Concentrated International ETF worth $30.7M.
- Brinker Capital Investments's largest Q2 2022 buy was BNY Mellon Concentrated International ETF: 773,041 shares worth $30.7M.
- Brinker Capital Investments added most to Franklin Systematic Style Premia ETF in Q2 2022, an estimated $22.9M increase.
- Brinker Capital Investments's biggest Q2 2022 reduction was iShares Russell 1000 Growth ETF, cutting an estimated $48.4M.
- Brinker Capital Investments fully exited First Trust Europe AlphaDEX Fund in Q2 2022, selling an estimated $37M.
- Brinker Capital Investments's ten largest holdings make up 17% of its $5.28B portfolio in Q2 2022.
- Brinker Capital Investments opened 74 new positions and closed 100 in Q2 2022.
- Brinker Capital Investments's portfolio value fell 19% quarter-over-quarter to $5.28B.
Based on Brinker Capital Investments's 13F filing for Q2 2022, filed 18 Jul 2022.